5 Deathbed Stocks

2 Recommendations

We’ve all head of the “death rattle,” the last gasp from a lost soul’s lungs. Sometimes, we seem to hear it from the companies in which we invest. Revenues dry up. Margins contract. Profits evaporate. All these signs suggest that their condition is worsening -- a financial death rattle, if you will.

Stocks in sick bay
Don’t assume that all such companies are goners. Some will barely cling to life, while others will make a full recovery. Sure it happens, but here we’re seeking companies that have all but given up the ghost.

For help, we’ll turn to the clever coroners at our 115,000-strong Motley Fool CAPS community, where members give the thumbs-up or thumbs-down to more than 5,500 stocks. Data shows that newly minted five-star stocks offer the best opportunities for investors, while the lowest-rated companies fared the worst. We’ve unearthed a handful of stocks that look like they might be headed six feet under and you might want to avoid as they’ve garnered no more than the lowest one-star rating.

Then we’ll check out some quick tests for liquidity -- the current ratio and quick ratio (also called the “acid test” ratio) -- which give us an idea of a company’s ability to pay its bills, and the Altman Z-Score which suggests companies in danger of bankruptcy. Companies scoring 3.00 and above are considered safe, between 2.70 and 2.99 are “yellow flags,” between 1.80 and 2.70 have a good chance of going bankrupt within two years, and those with scores below 1.80 mean the gravedigger is waiting.

Here’s today’s list. The question is, are these companies only mostly dead, or have they already given up the ghost?

Stock

Current Ratio

Acid-Test Ratio

Altman Z-Score

Ariba (Nasdaq: ARBA)

0.7

0.7

(7.06)

Children's Place (Nasdaq: PLCE)

1.8

0.5

4.41*

Earthlink (NYSE: ELNK)

3.1

3.0

2.22

SIGA Technologies (Nasdaq: SIGA)

4.3

3.9

1.17

UTStarcom (Nasdaq: UTSI)

1.4

0.4

1.24

Sources: Motley Fool CAPS; Capital IQ, a division of Standard & Poor's.
*As of May 3, 2008.

We obviously don’t know if these companies are headed six feet under, so don’t short them based on their appearance here. Moreover, some companies don’t neatly fit into the Altman Z-Score scale. Yet our primary screen is for those stocks that CAPS investors have marked down to one-star status, meaning they are possibly destined to seriously underperform the market.

A market disconnect
A deal to bring Internet protocol TV to India that will include live television, video-on-demand, and gaming. Couple that with a text messaging dream phone offered through Verizon (NYSE: VZ) and investors are beginning to think that talk of UTStarcom's demise may be premature. CAPS member xplorshinji thinks it's only a matter of time before it becomes a multibagger:

IPTV needs time to implement and roll out to the masses. Good headway in India and expanding outside of china. OPEX is still an issue resulting in cash burn. Once the contracts rolls in and more cost cutting happens, this stock should be a few bagger.

Supply chain management would seem to be a natural spot for the concept of software as a service under a more loosely defined rubric of cloud computing. Driving it will be new suppliers and falling prices, and while a suite of apps from Google (Nasdaq: GOOG) can't be dismissed either, it's just those sort of factors which CAPS member happyskippy sees as being the undoing of supply chain manager Ariba:

Supply chain is a great place to be but [Ariba] isn't it. Why?

Over paid managements, arrogance and poor execution. They have wrapped themselves in the Software as a Service software banner and that is what is driving much of the price runup. Wait til the IPO market opens up and other SaaS players are available to investors. Then let's see how they stack up.

For me, I am keeping my money in other places - not [Ariba]

CAPS member JPresbrown thinks investors have moved too early in bidding up Children's Place stock:

Everyone is so eager to be in consumer discretionary stocks before the economy turns that this stock has nearly tripled off its 52-week low. Good company, but an expensive stock. Recent push to $40 brought out heavy insider selling too. Dangerous stock to buy near highs with likely poor Christmas retail season ahead.

Rattling the cage
Are these companies doomed to drag their investors into an underworld of underperformance? Or will they be resurrected to stalk the markets once again? It pays to start your own research on these stocks on Motley Fool CAPS. Read a company’s financial reports, scrutinize key data and charts, and examine the comments your fellow investors have made all from a stock's CAPS page. Sign up today, absolutely free, and let us know whether you think the Grim Reaper’s at the door.

What do the unfolding financial crisis and ongoing market volatility mean for your money? The Fool's here with answers. Get the best of our daily commentary and analysis in your inbox simply by entering your email address in the box below.

Google is a Motley Fool Rule Breakers recommendation. Try any of our Foolish newsletters today, free for 30 days.

Fool contributor Rich Duprey does not have a financial interest in any of the stocks mentioned in this article. You can see his holdings here. The Motley Fool’s disclosure policy is full of life.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • On September 10, 2008, at 10:02 PM, jeffsfn wrote: Report this Comment

    I beg to differ with your analysis of SIGA. You say deathbed stocks are ones where "revenues dry up," "margins contract," and "profits evaporate."

    How is it that you rate this stock so terribly when just last week it won a $55 million dollar contract? Please answer me this.

    In 2006, it won far less money, and the stock jumped from the $2-$3 range to as high as nearly $6 in about a month.

    More, you have heralded SIGA as a stock with real potential in past articles. Why the abrupt turnaround hot on the heels of a $55 million contract?

    It seems as if SIGA suffers from terrible manipulation, possibly from hedge funds, but I would not categorize it as having dried up revenues with $55 million fresh in its coffers.

    Would you?

    Sincerely,

    Jeff

    SIGA investor

  • On September 11, 2008, at 4:49 AM, PSTech7 wrote: Report this Comment

    Granted, this biostock has under-performed but it certainly has not turned itself over and begun the death-kick. Siga's financials look quite healthy, it's 2 leading drugs very promising, it's recent steps in applying for FDA and European considerations, and it's ability to have funds available to them should they need them, make for a stock that 'Deserves Your Support'.

    I agree with the above poster . . . Siga is suffering from manipulation. This investor is doing what so many others are doing . . . shorting, buying, riding, and doing it again, and again, and again.

    Another 20 million is grants/contracts is right around the corner.

Add your comment.

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 724755, ~/articles/articlehandler.aspx, 11/22/2008 10:35:50 AM,

Sign up for FREE Motley Fool site access!

Already registered? Login Here

It’s FREE! Enter your email address, and we’ll rush you to the article you're looking for right now.

Privacy / Legal Information

We will use your email address only to keep you informed about updates to our web site and about other products and services that we think might interest you. The Motley Fool respects your privacy. Please read our Privacy Statement

.

Related Tickers

Ariba, Inc.

ARBA Up! $7.35 +1.21 (+19.71%) 4:00 PM
CAPS Rating:
77 Outperforms
27 Underperforms
Rate This Stock

Major Indices

S&P 500800.03+6.32%
DJIA8,046.42+6.54%
NASD1,384.35+5.18%
Updated: 4:07:36 PM
Sponsored by:

The Motley Poll

What changes are you making to your portfolio?

Sponsored by: